☆ 4.2 Review

ABO blood group and risk of COVID-19 infection and complications: A systematic review and meta-analysis

TRANSFUSION (2022)

Get Full Text
Add to Collection

Journal

TRANSFUSION
Volume 62, Issue 2, Pages 493-505

Publisher

WILEY
DOI: 10.1111/trf.16748

Keywords

ABO blood group; COVID-19; meta-analysis; systematic review

Categories

Hematology

Funding

  1. Vifor Pharma Espana
  2. Zambon(R)
  3. Bial(R)
  4. Terumo(R)
  5. Hemonetics(R)
  6. Inmucor(R)
  7. Abbott(R)
  8. Roche(R)
  9. Macopharma(R)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.